Clinical trials in Haiti
76 studies list at least one site in Haiti. 6 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-21.
Status
- Completed
- 55
- Active, not recruiting
- 5
- Terminated
- 5
- Recruiting
- 4
- Status unknown
- 4
- Not yet recruiting
- 2
Phase
- Phase 2
- 20
- Phase 4
- 10
- Phase 3
- 6
- Phase 1
- 5
Most studied here
Who runs them
National Institute of Allergy and Infectious Diseases (NIAID) (19) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (10) · Brigham and Women's Hospital (5) · Weill Medical College of Cornell University (5) · Centers for Disease Control and Prevention (4) · Washington University School of Medicine (4) · University of Florida (2) · International Maternal Pediatric Adolescent AIDS Clinical Trials Group (2)
Studies
Recruiting first, then most recently updated. Showing 50 of 76 — search for more.
- Trial of Novel Regimens for the Treatment of Pulmonary TuberculosisRecruitingNCT06192160Phase 2
- Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV RemissionRecruitingNCT02140255Phase 1/2
- A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)Not yet recruitingNCT07595042Phase 2
- A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIVNot yet recruitingNCT07124559Phase 1/2
- Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBIRecruitingNCT03474029Phase 2/3
- Improving Nighttime Access to Care and Treatment; Part 4-HaitiRecruitingNCT05480930Not applicable
- Short-course Regimens for the Treatment of Pulmonary TuberculosisActive, not recruitingNCT05766267Phase 2/3
- Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TuberculosisActive, not recruitingNCT05556746Phase 2
- Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIVCompletedNCT02906007Phase 1/2
- Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST StudyTerminatedNCT04311502Phase 2
- Establishing Optimal Number of Doses for HPV Vaccination in Children and Adolescents Living With HIV, OPTIMO TrialCompletedNCT04265950Phase 4
- Grandi Byen: Test of an Integrated Parenting and Nutrition InterventionCompletedNCT04785352Not applicable
- Linezolid Dosing Strategies in Drug-Resistant TBCompletedNCT05007821Phase 2
- A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in HaitiActive, not recruitingNCT03892265
- Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIVCompletedNCT05154513
- Haiti Community Health Workers (CHW) AdaptationCompletedNCT05091710Not applicable
- Evaluating the Use of Pitavastatin to Reduce the Risk of Cardiovascular Disease in HIV-Infected AdultsCompletedNCT02344290Phase 3
- Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsActive, not recruitingNCT03568383Phase 3
- Preventing Violence by Teachers in Primary Schools in HaitiCompletedNCT05081622Not applicable
- TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening RegimensCompletedNCT02410772Phase 3
- REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) TreatmentCompletedNCT01380080Phase 4
- Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected IndividualsTerminatedNCT04272242Phase 2
- Analysis of Risk Factors for Surgical Site Infections in Patients With Acute Abdomen at Hospital of State University of HaitiCompletedNCT06480344
- Leveraging Community Health Workers to Combat COVID-19 and Mental Health Misinformation in Haiti, Malawi, and RwandaActive, not recruitingNCT05997511Not applicable
- Treatment of Early Hypertension Among Persons Living With HIV in HaitiCompletedNCT04692467Phase 2
- FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in HaitiCompletedNCT03286504Not applicable
- First-Sight Refractive Error Correction in the Developing WorldCompletedNCT01598818
- Monitoring Drug Efficacy and Anthelmintic Resistance in Soil-transmitted Helminth ProgramsCompletedNCT04177654
- Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLDCompletedNCT04050449
- IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum WomenCompletedNCT00955968Phase 4
- High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB)CompletedNCT01936831Phase 2
- Dietary Intake, Health and Micronutrient Status in HaitiTerminatedNCT04034381
- Social Determinants of Global Pediatric DiabetesStatus unknownNCT04272099
- Application of Powdered Vancomycin in the Surgical Wound in HaitiCompletedNCT05535725Phase 4
- A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIVCompletedNCT03154320Not applicable
- Improving Nighttime Access to Care and Treatment (Part 2)CompletedNCT03943654
- An Observational Study of Long-term Outcomes of HIV-1 Infection in Persons Who Become HIV-1 Infected After Enrollment in HIV-1 Vaccine TrialsCompletedNCT03337906
- Prevalence of Iodine Deficiency in Remote Communities of HaitiStatus unknownNCT05275452
- Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant WomenCompletedNCT01494038Phase 4
- Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During PregnancyCompletedNCT00099632Phase 2
- Evaluating PK, Tolerability, and Safety of Rifapentine and Isoniazid in Pregnant and Postpartum WomenCompletedNCT02651259Phase 1/2
- Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)CompletedNCT01404312Phase 3
- HVTN Protocol 204 - A Phase II Clinical Trial to Evaluate the Safety and Immunogenicity of a Multiclade HIV-1 DNA Plasmid Vaccine, VRC-HIVDNA016-00-VP, Followed by a Multiclade Recombinant Adenoviral Vector HIV-1 Vaccine Boost, VRCHIVADV014-00-VP, in HIV-1 Uninfected Adult ParticipantsCompletedNCT00125970Phase 2
- ALVAC-HIV vCP1452 Alone and Combined With MN rgp120CompletedNCT00011037Phase 2
- Immediate Fast-Track Versus Standard Care for Persons Living With HIV in HaitiCompletedNCT03358927Not applicable
- Death to Onchocerciasis and Lymphatic Filariasis (DOLF) Triple Drug Therapy for Lymphatic FilariasisCompletedNCT02899936Not applicable
- Prevalence Studies After Triple Drug Therapy for Lymphatic FilariasisCompletedNCT03352206
- Trial for Safety and Immunogenicity of a Chikungunya Vaccine, VRC-CHKVLP059-00-VP, in Healthy AdultsCompletedNCT02562482Phase 2
- A 14 Day Early Bactericidal Activity Study of Nitazoxanide for the Treatment of TuberculosisCompletedNCT02684240Phase 2
- Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed AdultsStatus unknownNCT04311957Phase 4